Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | March 2026 | YoY |
|---|---|---|
| Revenue | 633.45m | - |
| Gross profit | 147.58m | - |
| Net profit | 39.32m | - |
| EBITDA | 92.4m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €897.07m |
Number of shares | 1.43bn |
52-week high/low | €0.74 - €0.62 |
Dividend yield | 4.49% |
Dividends TTM | €0.0301 |
Beta | 0.07 |
P/E ratio | 2.60 |
PEG ratio | 0.00 |
P/B ratio | 1.57 |
P/S ratio | 0.70 |
Company profile
Leo Holdings Corp. II does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Leo Holdings Corp. II was incorporated in 2020 and is based in Nassau, the Bahamas.
| Name | Life Healthc.Gr. Pte |
| CEO | Peter Gerard Wharton-Hood Harvard |
| Headquarters | Johannesburg,
gt United Kingdom |
| Website | |
| IPO | 01/03/2021 |
| Employees | 16,108 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Jnb | LHC.JO |
Pnk | LTGHF |
Frankfurt | L53.F |
Düsseldorf | L53.DU |